Eric W. Hoffman
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research, vaccines and immunoinformatics approaches, Glycosylation and Glycoproteins Research, RNA Interference and Gene Delivery
Most-Cited Works
- → The Banff 97 working classification of renal allograft pathology(1999)3,045 cited
- A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.(2003)
- → Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans(2004)438 cited
- → Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers(2000)426 cited
- → Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients(2012)272 cited
- → Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer(2007)266 cited
- → Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant(2008)244 cited
- → A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors(2007)217 cited
- → Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients(2006)214 cited
- → Filgrastim in Patients with Chemotherapy-Induced Febrile Neutropenia: A Double-Blind, Placebo-Controlled Trial(1994)195 cited